Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of ZBTB16 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ZBTB16 mRNA | affects expression | 17562736
|
D001151 |
Arsenic |
Arsenic results in decreased expression of ZBTB16 mRNA | decreases expression | 19654921
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ZBTB16 mRNA | affects cotreatment|increases expression | 18164116
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ZBTB16 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of ZBTB16 mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ZBTB16 mRNA | affects cotreatment|increases expression | 18164116
|
D004610 |
Ellagic Acid |
Ellagic Acid results in decreased expression of ZBTB16 mRNA | decreases expression | 12002526
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of ZBTB16 mRNA | affects cotreatment|increases expression | 17404688
|
C016599 |
mono-(2-ethylhexyl)phthalate |
mono-(2-ethylhexyl)phthalate results in increased expression of ZBTB16 mRNA | increases expression | 16809437
|
D010126 |
Ozone |
Ozone results in increased expression of ZBTB16 mRNA | increases expression | 17460151
|
C041786 |
palm oil |
palm oil results in decreased expression of ZBTB16 mRNA | decreases expression | 18042831
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ZBTB16 mRNA | increases expression | 18445702
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of ZBTB16 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of ZBTB16 mRNA | increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone affects the expression of ZBTB16 mRNA | affects expression | 17251523
|
C059514 |
resveratrol |
resveratrol results in decreased expression of ZBTB16 mRNA | decreases expression | 12002526
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of ZBTB16 mRNA | increases expression | 17682005
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ZBTB16 mRNA | increases expression | 20055451
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
8.45 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.45 | 11752688 14514962 15322242 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.83 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.09 | 11473722 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
11.23 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.23 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
11.23 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.24 | 18056438 16434500 17620307 17162532 19061943 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.24 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.24 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.70 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
13.79 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
13.79 | 17306315 16712894 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.37 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.37 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.84 | 10982225 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.86 | 18414634 16251483 12569548 16835338 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.87 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
3.49 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.55 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.63 | 16373670 17854713 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
6.85 | 12928151 19371607 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.85 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.71 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.34 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.24 | 15380490 15665606 15845082 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.27 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.95 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.95 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.95 | 17261762 16675129 17289903 18497071 12948864 17018787 19861407 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.95 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.95 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.95 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.66 | 15516495 14754758 19059883 18417511 16777450 18315731 17626835 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.73 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.45 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.58 | 15504454 17687452 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.36 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
11.36 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.36 | 3084413 18056438 18506893 16288022 18393292 18788625 18785209 16502159 20084675 19171122 17978847 11831363 19394651 16779866 17761372 3581430 19539802 19335982 19052882 18971187 20524982 16698587 19519916 10737359 16807293 16878318 19701751 20727157 18210153 18665156 20935162 20214788 17138121 17173139 17428255 19418558 10672840 16569478 16328049 16830150 17055752 20514400 20101231 17162532 19208518 19822196 20007298 19383236 19107877 16935385 18978308 20512989 18494052 21159647 20432363 19919837 16540662 16681979 18691550 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.36 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
11.36 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.36 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.58 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
7.62 | 18922899 15504454 17687452 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.62 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.62 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.06 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
7.52 | 15738583 17938729 19152805 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.52 | 15458977 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.29 | 16973168 18022660 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.38 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.38 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.90 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
15.90 | 2727394 7505956 21159647 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.90 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.90 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.26 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.70 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 12621046 8697196 15340226 15668235 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.11 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.45 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.22 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.13 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.13 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.74 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 20055451 10048152 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.75 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.20 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.20 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.96 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.96 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.48 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
8.93 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.93 | 16393943 16177239 19370779 18713872 2444490 10915739 15968718 14550746 17522070 14986274 15619225 11739529 16485898 16081117 19923254 19085960 10774834 12594235 12392966 11461765 11421492 17906064 19164858 18071297 17562736 11834606 12540782 16227642 11287661 11743745 14725611 16781746 19420014 16109766 12958197 10663392 19416960 12705907 19739265 11529661 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.93 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.93 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.10 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.44 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.33 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
11.33 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.33 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
9.29 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.29 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.97 | 18566989 11473722 19148513 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.87 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.87 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.83 | 17923197 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.12 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.61 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
18.61 | 18296743 19551842 17967931 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
18.61 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.61 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.65 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.65 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.65 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.56 | 6392382 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.68 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.67 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.52 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.22 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.22 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.03 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.17 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.13 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.75 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 16959395 15340226 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.68 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
9.15 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
9.15 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.44 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
9.23 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
9.23 | 16873680 |
MESH:D006973 |
Hypertension |
|
Arsenic |
8.54 | 11953799 9931084 16076760 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.54 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.54 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.28 | 17488730 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.56 | 16093927 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
11.44 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
11.44 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.97 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
15.76 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
15.76 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
15.76 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
15.76 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.76 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.54 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.21 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.21 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.21 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.98 | 16930632 12749816 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.32 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.32 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.32 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.32 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.21 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.21 | 15610895 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.87 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
7.87 | 16087638 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.60 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.60 | 18665156 20032147 19638242 18522880 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.36 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.36 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.36 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.50 | 12587719 16611625 19014921 16610002 11587558 19460945 12969438 19784758 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
6.50 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.50 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.22 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
21.81 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
21.81 | 19389873 21295105 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
21.81 | 12112319 19551842 19426721 15885732 19638242 19294768 18644402 2422723 10737359 20137499 19499222 19996281 19256749 19073162 20452335 21167192 18754104 19642983 21278145 19090486 20405173 20434301 20492335 18977376 19812893 19850985 9163691 2862719 19255062 16942905 19690152 20101389 15175105 21047994 12771043 19833225 19427195 21071580 20501860 20118626 20583210 18978307 19254457 18648771 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
21.81 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
21.81 | 19812893 20405173 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
21.81 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
21.81 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
9.79 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
9.79 | 2563599 18253720 19009564 18544905 9362446 17942915 18308698 18775883 18093689 18079962 19519916 18164116 17854601 19539802 19126423 3124819 17174075 21159647 16842330 18282651 16267830 19004024 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.79 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.47 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.47 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.83 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
6.57 | 19168569 17976673 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.57 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
6.57 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.57 | 17077188 19931552 15276417 16712894 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.57 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.28 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.85 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.24 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.96 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.96 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
9.96 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.48 | 19453300 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.48 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.48 | 19082730 16487513 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.55 | 19513568 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.36 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.11 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.45 | 17049120 17164350 16490592 16267019 17935668 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.86 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.71 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.71 | 16456233 16317513 17015251 16525036 17188708 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
15.20 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
15.20 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
15.20 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.19 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.19 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.75 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.56 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.91 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.91 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
9.18 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
9.18 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.72 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.41 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.41 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
7.41 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.41 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
13.95 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
13.95 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
13.95 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
10.64 | 17056641 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
10.64 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.12 | 20387270 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.42 | 17217161 21332399 20518802 19632207 18457598 16723640 18674790 11836018 20132043 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.42 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.08 | 14694615 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.24 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
11.27 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.27 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.27 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.27 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.37 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.41 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.16 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.98 | 15371236 6392382 16905509 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.12 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.39 | 18007984 18381685 18929643 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.88 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.88 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.56 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.56 | 11222880 11896295 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.11 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.11 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.11 | 16731767 17804756 15767336 17636462 17675339 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.11 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.99 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.58 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.54 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.54 | 15827377 16317513 16314181 17058453 17520802 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.85 | 18045962 |
OMIM:612447 |
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION |
marker/mechanism |
|
| |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.74 | 17938729 16353154 17548696 18709164 17453740 16702368 15952646 17050553 6392382 16759981 19834688 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
13.52 | 17976673 17050553 17029826 19538983 16251483 15504454 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.52 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.52 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.52 | 16192470 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.27 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.78 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.46 | 16321402 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.97 | 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.69 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.19 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.26 | 17976673 19429237 15987713 17306315 19322015 18640142 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.26 | 16452187 17306315 11723127 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.96 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.50 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.50 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.12 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
11.82 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.82 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.29 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.72 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |